Trailing-twelve-month (TTM) revenue is $1.52 Billion with a year-over-year growth of +40.03%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-27 | $299,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q2 FY2026Period ended 2025-12-27 | $369,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-29 |
| Q3 FY2026Period ended 2026-03-28 | $406,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q4 FY2026Period ended 2026-06-27 | $443,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $1,518,300,000 |
Current P/S: $8,930,020,421 market capitalization ÷ $1,518,300,000 TTM revenue = 5.88x.
Market capitalization source: FMP quote. Quote observed 2026-09-21T20:00:00.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-27): $443.10M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-22T00:16:43.025Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-06-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-07-03 · USD | FY20222022-07-02 · USD | FY20232023-07-01 · USD | FY20242024-06-29 · USD | FY20252025-06-28 · USD | FY20262026-06-27 · USD |
|---|---|---|---|---|---|---|
| Product | $1.1B | $1.1B | $936M | $835M | $912M | $1.3B |
| Service | $148M | $157M | $170M | $166M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-07-03 · USD | FY20222022-07-02 · USD | FY20232023-07-01 · USD | FY20242024-06-29 · USD | FY20252025-06-28 · USD | FY20262026-06-27 · USD |
|---|---|---|---|---|---|---|
| Americas | $416M | $486M | $438M | $391M | $425M | $683M |
| Asia Pacific | $411M | $462M | $378M | $347M |
$1.52B
$1.52 Billion
+40.03%
vs. $1.08B a year ago (TTM)
+5.37%
5 Year compound annual growth rate
1 Year
+40.03%
3 Year
+8.16%
5 Year
+5.37%
10 Year
+3.11%
15 Year
(0.83%)
20 Year
+1.81%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $1.52B | +$434.00M | +40.03% |
| 2025 | $1.08B | +$83.90M | +8.39% |
| 2024 | $1.00B | ($105.70M) | (9.56%) |
| 2023 | $1.11B | ($186.30M) | (14.42%) |
| 2022 | $1.29B | +$93.50M | +7.80% |
| 2021 |
TTM Growth
+40.03%
3-Year CAGR
+8.16%
5-Year CAGR
+5.37%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-22T00:16:43.025Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $172M |
| $194M |
| $470M |
| EMEA | $373M | $345M | $291M | $263M | $280M | $365M |
|---|
| $1.20B |
| +$62.60M |
| +5.51% |
| 2020 | $1.14B | +$6.00M | +0.53% |
| 2019 | $1.13B | +$254.60M | +29.07% |
| 2018 | $875.70M | +$64.30M | +7.92% |
| 2017 | $811.40M | ($94.90M) | (10.47%) |
